| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/12/2006 | US7105161 Proteinaceous adjuvants |
| 09/12/2006 | CA2251060C Acylated n-hydroxy methyl thalidomide prodrugs with immunomodulator action |
| 09/12/2006 | CA2247179C Use of il-7 for treating auto-immune diseases and insulin-dependent diabetes mellitus in particular |
| 09/08/2006 | WO2006094134A2 Kim-1 antibodies for treatment of th2-mediated conditions |
| 09/08/2006 | WO2006093745A1 Purification of rapamycin |
| 09/08/2006 | WO2006093352A1 Compound having cyclic structure and use thereof |
| 09/08/2006 | WO2006093313A1 T cell apoptosis inducer |
| 09/08/2006 | WO2006093267A1 Fermentation composition having immunomodulating effect |
| 09/08/2006 | WO2006093247A1 NOVEL AMINOPYRIDINE COMPOUND WITH Syk INHIBITORY ACTIVITY |
| 09/08/2006 | WO2006093226A1 Antipruritic agent |
| 09/08/2006 | WO2006093205A1 Method and device for cell preparation |
| 09/08/2006 | WO2006093202A1 Phloroacylphenone glycoside, process for production of the same, antiallergic agent and antioxidant |
| 09/08/2006 | WO2006093194A1 Antiallergic composition |
| 09/08/2006 | WO2006093175A1 High-molecular fucoidan, method of producing the same and cosmetic composition |
| 09/08/2006 | WO2006093118A1 Drug and food composition for enhancing immune responce containing at oligonucleotide as the active ingredient |
| 09/08/2006 | WO2006093022A1 Immune function modulating agent |
| 09/08/2006 | WO2006092908A1 Type i allergy inhibitor and methods of inhibiting the onset of type i allergy using fulvic acid |
| 09/08/2006 | WO2006092741A2 Treatment of inflammatory disorders with praziquantel |
| 09/08/2006 | WO2006092739A1 Anti-inflammatory conjugates of macrolides and coumarins |
| 09/08/2006 | WO2006092623A1 Cytokine modulators using cyclic glycerides of essential polyunsaturated fatty acids |
| 09/08/2006 | WO2006092580A1 Combination therapy |
| 09/08/2006 | WO2006064373A3 Methods of purifying immunologlobulins |
| 09/08/2006 | WO2006029010A3 Methods of activating nkt cells |
| 09/08/2006 | CA2600118A1 Fermented compositions having immunomodulatory actions |
| 09/08/2006 | CA2599967A1 Kim-1 antibodies for treatment of th2-mediated conditions |
| 09/08/2006 | CA2599909A1 Immune function modulating agents |
| 09/08/2006 | CA2599867A1 Antiallergic composition |
| 09/08/2006 | CA2599582A1 Purification of rapamycin |
| 09/08/2006 | CA2599544A1 Novel aminopyridine compound with syk inhibitory activity |
| 09/08/2006 | CA2598785A1 Cytokine modulators using cyclic glycerides of essential polyunsaturated fatty acids |
| 09/07/2006 | US20060199957 Novel bicyclic and tricyclic cannabinoids |
| 09/07/2006 | US20060199856 Dihydroorotate dehydrogenase (DHODH) inhibitors; Rheumatoid arthritis, Pneumocystis carinii, fibrosis, uveitis, rhinitis, asthma, and athropathy; 2-(Biphenyl-4-ylcarbamoyl)-cyclopent-1-enecarboxylic acid |
| 09/07/2006 | US20060199827 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/07/2006 | US20060199825 4-Aminating a 4-chloro-2-hydroxy-3-nitrodihydroquinoline with a N-(hetero)cyclylpiperazine, and alkylating the remaining amine group in the quinoline ring to produce a 4-(4-(hetero)cyclylpiperazinyl)-3-nitro-1-alkyldihydroquinolinone |
| 09/07/2006 | US20060199795 e.g. 2-[3,5-trans-5-(3-aminophenyl)-7-chloro-1-neopentyl-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-N-(2-fluorobenzyl)acetamide; G-protein-coupled receptor (TGR5) agonist; central nervous system diseases; antiinflammatory agent; learning enhancement; angina pectoris, arrhythmia, bronchial asthma |
| 09/07/2006 | US20060199792 Peroxynitrite decomposition catalysts and methods of use thereof |
| 09/07/2006 | US20060199770 Functionalized carbon nanotubes, a process for preparing the same and their use in medicinal chemistry |
| 09/07/2006 | US20060199177 T helper cell epitopes |
| 09/07/2006 | US20060198871 Methods for treating neovascularization and intravitreal implants |
| 09/07/2006 | US20060198846 Combinations for the treatment of diseases involving angiogenesis |
| 09/07/2006 | US20060198840 increased in vivo half-lives due to the presence of an immunoglobulin G (IgG) constant domain; pharmacokinetics; diagnosis or immunotherapy; antibody conjugates; palivizumab |
| 09/07/2006 | US20060198834 Method of administration of cpn10 to a donor and/or recipient animal or cells, tissues or organs derived from the donor; in a particularly advantageous form treatment of both the donor and recipient animal; treatment and/or prevention of graft versus host disease |
| 09/07/2006 | US20060196500 Closure-cap and container as a two-chamber cartridge for nebulisers for producing aerosols and active substance formulations, suitable for storage |
| 09/07/2006 | DE102005009515A1 Verfahren zur Herstellung einer Zubereitung einer DMSO-haltigen festen Silikonölemulsion zur Bindung von reaktiven Sauerstoffverbindungen im Körper von Menschen und Tieren A process for the preparation of a composition of a DMSO-containing solid silicone oil emulsion for binding of reactive oxygen species in the body of humans and animals |
| 09/06/2006 | EP1698701A1 Use of MHC class II ligands as adjuvant for vaccination and lag-3 in cancer treatment |
| 09/06/2006 | EP1698627A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/06/2006 | EP1698624A1 Phenylpropanoic acid derivatives |
| 09/06/2006 | EP1698620A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions |
| 09/06/2006 | EP1698347A2 hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 09/06/2006 | EP1698345A2 Peptide antagonists of zonulin and methods for use of the same |
| 09/06/2006 | EP1698334A1 Pharmaceutically active isoindoline derivatives |
| 09/06/2006 | EP1697371A1 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 09/06/2006 | EP1697370A1 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 09/06/2006 | EP1697351A1 2,6-bisheteroaryl-4-aminopyrimidines as adenosine receptor antagonists |
| 09/06/2006 | EP1696964A1 Use of microparticles for antigen delivery |
| 09/06/2006 | EP1696955A2 Detection of cd20 in therapy of autoimmune diseases |
| 09/06/2006 | EP1696942A1 Pharmaceutical product comprising tissue of the male vegetal reproductive system |
| 09/06/2006 | EP1406609B1 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 09/06/2006 | EP1401814B1 Derivatives of 3-phenyl-n-(2- (4-benzyl) piperidin-1-yl)-ethyl)-acrylamid with ccr-3 receptor antagonistic activity for use in the treatment of inflammations and allergic conditions |
| 09/06/2006 | EP1349553B1 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
| 09/06/2006 | EP1322383B9 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 09/06/2006 | EP1223933B1 5-membered heterocycle derivatives and use thereof as monoaminoxidase inhibitors |
| 09/06/2006 | EP1214350B1 Peptides for combating the autoantibodies that are responsible for dilatative cardiomyopathy (dcm) |
| 09/06/2006 | EP1204418B1 Compositions containing muscle-derived active agents |
| 09/06/2006 | EP1071449B1 Use of an antagonist antibody to the inflammatory mediator oncostatin m (osm) |
| 09/06/2006 | EP1027373B1 Muc-1 derivatives and their use in treating cancer-associated muc-1 mucin-induced immunosuppression |
| 09/06/2006 | CN1829712A Nicotinamide derivatives useful as PDE4 inhibitors |
| 09/06/2006 | CN1829535A Sphingoid polyalkylamine conjugates for vaccination |
| 09/06/2006 | CN1827649A Fusion toxin protein and uses thereof |
| 09/06/2006 | CN1827168A Treatment of t cell mediated autoimmune disorders |
| 09/06/2006 | CN1827167A Animal medicine capable of increasing immunologic function of livestock and birds |
| 09/06/2006 | CN1827163A Technique for preparing animal medicine with immunity-improving function |
| 09/06/2006 | CN1827162A Animal medicine capable of resisting multiple irritated stress of chicken |
| 09/06/2006 | CN1827100A Pharmaceutical composition using ramatroban as active ingredient, its preparation method and use |
| 09/06/2006 | CN1826974A Health seasoning |
| 09/06/2006 | CN1826923A Method for preparing brain-caring health-preserving instant soluble tea |
| 09/06/2006 | CN1826917A Health drink with milk and snow lotus live body and preparation method |
| 09/06/2006 | CN1273488C Gene reform immune globulin with low immunogenicity and its application |
| 09/06/2006 | CN1273463C (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for production thereof and pharmaceutical compositions containing the same |
| 09/06/2006 | CN1273197C Construction method for mouse skin allergy animal model |
| 09/06/2006 | CN1273192C Method and composition for altering a T cell mediated pathology |
| 09/06/2006 | CN1273191C Method and composition for altering a B cell mediated pathology |
| 09/06/2006 | CN1273168C Health-care liquid |
| 09/06/2006 | CN1273147C Supercritical CO2 method for extracting effective constituent from whole spores of ganoderma lucidum |
| 09/06/2006 | CN1273110C System treatment of a mucosal surface |
| 09/06/2006 | CN1273048C Lily bulb health-care product |
| 09/05/2006 | USRE39267 Thienopyrimidine-based inhibitors of the SRC family |
| 09/05/2006 | US7102013 Treating under hydrolyzing conditions a hydantoin compound to form an alpha-amino acid derivative |
| 09/05/2006 | US7102009 For treating cancer and angiogenesis-related disorders |
| 09/05/2006 | US7101974 Tumor necrosis factor ptotein; for use in the treatment of rheumatic diseases and arthritis |
| 09/05/2006 | US7101915 P-terphenyl compounds |
| 09/05/2006 | US7101911 Bis(substituted propynyl)-substituted benzenes, pyridines, pyrimidines, pyrazines, pyridines, furans and pyrroles; e.g., 3,5-bis-(3-(4-aminomethylbenzylaminocarbonyloxy)prop-1-ynyl)--1 -hydroxymethylbenzene |
| 09/05/2006 | US7101882 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 09/05/2006 | US7101877 Trans-[2-(4-Morpholinyl)-1-(2-Naphthenethoxy)]Cyclohexane Monohydrochloride; selectively inhibiting cardiac early repolarising currents and cardiac sodium currents |
| 09/05/2006 | US7101868 A 2-(((4-fluorophenyl)methyl)amino)-3-pyridinecarboxamide derivatives for treating cancer, angiogenesis, tumor |
| 09/05/2006 | US7101866 6,9-Difluoro-17 alpha -((2-furanylcarbonyl)oxy)-11 beta -hydroxy-16 alpha -methyl-3-oxo-androsta-1,4-diene-17 beta -carbothioic acid S-fluoromethyl ester; antiinflammatory agents for the treatment of allergic conditions |
| 09/05/2006 | US7101865 24-sulfoximine vitamin D3 compounds |
| 09/05/2006 | US7101860 Composition and method for inhibiting platelet aggregation |
| 09/05/2006 | US7101856 Thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof |
| 09/05/2006 | US7101851 IgE receptor antagonists |